Work for IntelliPharmaCeutics International Inc.?

Claim Your Profile

IntelliPharmaCeutics International Inc. Logo Image

IntelliPharmaCeutics International Inc.

IntelliPharmaCeutics International Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report

IntelliPharmaCeutics International Inc.

IntelliPharmaCeutics International Inc. has reached its limit for free report views.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

Archived Annual Reports

About IntelliPharmaCeutics International Inc.

51-200 Employees
Based in Etobicoke, Toronto

Since 1998, Intellipharmaceutics has been an innovator in the international pharmaceutical market. The Company’s patented Hypermatrix™ technology is a unique and validated multidimensional controlled-release drug delivery platform that can be applied to the development of a wide range of existing and new pharmaceuticals. Based on this technology, Intellipharmaceutics is developing a pipeline of both generic and new drugs across a range of therapeutic classes.

Ticker:
IPCI
Exchange:
TSX (See More TSX Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol